Search
Now showing items 1-10 of 29
Preprint
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants
| Date Issued:
2021 | Copyright:
open access
Article
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
| Date Issued:
2022 | Copyright:
open access
Article
A call to action for translational sciences in COVID-19 and future pandemics
| Date Issued:
2022 | Copyright:
open access
Article
SARS-CoV-2 Molecular Epidemiology Can Be Enhanced by Occupational Health: The Experience of Monitoring Variants of Concern in Workplaces in Rio de Janeiro, Brazil
| Date Issued:
2022 | Copyright:
open access
Article
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
| Date Issued:
2022 | Copyright:
open access
Preprint
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Date Issued:
2022 | Copyright:
open access
Article
A Biosafety Level 2 Mouse Model for Studying Betacoronavirus- Induced Acute Lung Damage and Systemic Manifestations
| Date Issued:
2021 | Copyright:
open access
Preprint
Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres
| Date Issued:
2020 | Copyright:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
| Date Issued:
2021 | Copyright:
open access
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Date Issued:
2020 | Copyright:
open access